David E Stableforth
Impact in
-
- Cystic Fibrosis Research Advances
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Respiratory Support and Mechanisms
- Physiology top 5%
- Asthma and respiratory diseases
Papers in
-
- Cystic Fibrosis Research Advances 26
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3
- Pleural and Pulmonary Diseases 3
- Chronic Obstructive Pulmonary Disease (COPD) Research 3
- Physiology 14
- Asthma and respiratory diseases 12
- Co-authors
- Lawrence Peter Ormerod (4 shared papers)Frank Peter Edenborough (11 shared papers)David L. Smith (5 shared papers)Michael Mulheran (3 shared papers)Dev Banerjee (2 shared papers)W. E. Mackenzie (4 shared papers)Ruth M. Cayton (4 shared papers)E. Grace Smith (6 shared papers)
- Journals
- Thorax (19 papers)Respiratory Medicine (6 papers)The Lancet (5 papers)Respiration (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)
- Partner nations
- United KingdomAustraliaDenmark
In The Last Decade
David E Stableforth
84 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 76
- Pulmonary and Respiratory Medicine 826
- Physiology 470
- Sensory Systems 56
- Pharmacology 91
- Gastroenterology 28
Countries citing papers authored by David E Stableforth
This map shows the geographic impact of David E Stableforth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E Stableforth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E Stableforth more than expected).
Fields of papers citing papers by David E Stableforth
This network shows the impact of papers produced by David E Stableforth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E Stableforth. The network helps show where David E Stableforth may publish in the future.
Co-authors
The 25 scholars most cited alongside David E Stableforth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 181 | |
| 2 | 1983 | 147 | |
| 3 | 1980 | 118 | |
| 4 | 1984 | 105 | |
| 5 | 2002 | 100 | |
| 6 | 1993 | 95 | |
| 7 | 2000 | 92 | |
| 8 | 2000 | 85 | |
| 9 | 2001 | 84 | |
| 10 | 1994 | 81 | |
| 11 | 1983 | 78 | |
| 12 | 1995 | 74 | |
| 13 | 1996 | 74 | |
| 14 | 1983 | 67 | |
| 15 | 1993 | 58 | |
| 16 | 2002 | 57 | |
| 17 | 1986 | 54 | |
| 18 | 1981 | 49 | |
| 19 | 1990 | 45 | |
| 20 | 1998 | 44 |
About David E Stableforth
David E Stableforth is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Sensory Systems, Infectious Diseases and Epidemiology, having authored 86 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (26 papers), Asthma and respiratory diseases (12 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Burkholderia infections and melioidosis (3 papers), Pleural and Pulmonary Diseases (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), Hearing, Cochlea, Tinnitus, Genetics (2 papers) and Transplantation: Methods and Outcomes (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (826 citations), Physiology (470 citations), Sensory Systems (56 citations), Pharmacology (91 citations) and Gastroenterology (28 citations). David E Stableforth has collaborated with scholars based in United Kingdom, Australia and Denmark. Frequent co-authors include Lawrence Peter Ormerod, Frank Peter Edenborough, David L. Smith, Michael Mulheran, Dev Banerjee, W. E. Mackenzie, Ruth M. Cayton, E. Grace Smith, Alan Robert Smyth and ADAM T. HILL. Their work appears in journals such as Thorax, Respiratory Medicine, The Lancet, Respiration and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.